A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
Clinical trial NCT03874832 · COMPLETED
Trial details
- NCT number
- NCT03874832
- Sponsor
- Satsuma Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-11
- Primary completion
- 2018-11-07
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.